vVardis Falls 22% in NYSE Debut After $175M IPO Priced Below Range
VVVV is trading near its 52-week low of $14 (6.6% above the low).
Summary
vVardis raised $175 million in its NYSE IPO but priced below the marketed range, and the stock fell 22% on its first day of trading. The weak debut follows this morning's pricing announcement and tells you demand was soft even at the reduced level. For a dental med-tech name selling the Curodont non-invasive cavity treatment brand, a broken IPO print is a rough start to public-market life. Apollo (APO) is tagged alongside but is not the subject of this story.
At the time of this announcement, VVVV was trading at $14.92 on NYSE in the Life Sciences sector. The 52-week trading range was $14.00 to $15.27. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.